- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02740673
Testing Cognitive Functions in Patients With COPD Using a Driving Simulator
April 30, 2019 updated by: Aarhus University Hospital
Little is known about the causes and degree of cognitive dysfunction in patients with Chronic Obstructive Pulmonary Disease (COPD), especially their driving abilities.
The purpose of the study is to examine the cognitive skills of patients with COPD by using a driving simulator and to examine correlations to factors that may predict cognitive dysfunction in these patients.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- a diagnosis of COPD (Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) < 0,70)
- no exacerbations within the last 6 weeks
- valid driver's license and having driven a car within the last 3 months
Exclusion Criteria:
- lacking the ability to use the driving simulator
- no valid driver's license
- alcohol abuse (> 21 units per week)
- a known diagnosis of obstructive sleep apnea
- uncorrected impaired vision or hearing
- unstable ischemic heart disease, left-sided heart failure, severe neurologic diseases, cancer, severe peripheral vascular disease, severe psychiatric diseases, former apoplexia and uncontrolled hypertension, thyroid diseases or diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Driving simulator
Using the driving simulator for 30 min.
|
Patients are asked to use a driving simulator to test their driving skills
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standard deviation from the centre of the road
Time Frame: During the 30 min. of driving in the simulator
|
Measuring how far from the centre of the road the patient has been driving in the driving simulation
|
During the 30 min. of driving in the simulator
|
|
Number of nil responses
Time Frame: During the 30 min. of driving in the simulator
|
Measuring the number of times the patients doesn't react to the number "2" on the screen
|
During the 30 min. of driving in the simulator
|
|
Response time
Time Frame: During the 30 min. of driving in the simulator
|
Measuring the mean amount of response time from the number "2" appears on the screen until the patient reacts
|
During the 30 min. of driving in the simulator
|
|
Number of off-road events per hour
Time Frame: During the 30 min. of driving in the simulator
|
The number of times the car is off-road during the driving simulation
|
During the 30 min. of driving in the simulator
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with comorbidities
Time Frame: At enrolment
|
Patients with comorbidities will be registered
|
At enrolment
|
|
Lung function tests
Time Frame: At enrolment
|
At enrolment
|
|
|
Depression and anxiety
Time Frame: At enrolment
|
Using the Hospital Anxiety and Depression Scale
|
At enrolment
|
|
Cognitive functions
Time Frame: At enrolment
|
Using the Mini Mental State Examination and the Clock Drawing Test
|
At enrolment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas S Prior, MD, Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2019
Primary Completion (Anticipated)
January 1, 2022
Study Completion (Anticipated)
January 1, 2022
Study Registration Dates
First Submitted
December 28, 2015
First Submitted That Met QC Criteria
April 12, 2016
First Posted (Estimate)
April 15, 2016
Study Record Updates
Last Update Posted (Actual)
May 2, 2019
Last Update Submitted That Met QC Criteria
April 30, 2019
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Driving simulator, COPD, v.2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Driving simulator
-
PSA Automobiles S.A.University of Bordeaux; University Hospital, BordeauxCompletedHealthy Subjects | Attention DeficitFrance
-
NYU Langone HealthCompleted
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruiting
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
University Hospital, BordeauxPREDIT Go4Completed
-
University of Kansas Medical CenterRecruitingStroke | Multiple Sclerosis | Parkinson DiseaseUnited States
-
University of ManitobaCompletedDementia | Spatial Navigation | Navigation, SpatialCanada
-
State University of New York at BuffaloCompletedAttention Deficit Hyperactivity DisorderUnited States